Department of Pediatrics, University of Washington, Seattle, WA, USA.
Department of Biostatistics, University of Washington, Seattle, WA, USA.
Early Hum Dev. 2021 Jul;158:105395. doi: 10.1016/j.earlhumdev.2021.105395. Epub 2021 May 19.
Iron deficiency during critical windows of brain development is associated with suboptimal neurodevelopmental outcomes. Identifying markers of neonatal iron status that best correlate with neurodevelopmental outcome is critical for optimal management of iron supplementation of neonates.
We aimed to evaluate two markers of iron sufficiency, ferritin and zinc protoporphyrin-to-heme ratios (ZnPP/H), with neurodevelopmental outcomes.
This is a retrospective cohort study.
All infants with concurrent ferritin and ZnPP/H measurements obtained between October 2014 and April 2017 and Bayley Scales of Infant Development, 3rd Edition (BSID-III) evaluated at 24 months corrected age were included.
Associations between iron markers (minimum, maximum and median ferritin and ZnPP/H) and BSID-III score at 24 months were assessed.
223 lab measurements from 62 infants were assessed. Mean gestational age was 28.1 weeks (SD = 2.6) with a mean birth weight of 1.1 kg (SD = 0.4). Significant associations between maximum and median ZnPP/H and motor score, and between median ZnPP/H and cognitive score were observed. Trends were also seen with higher minimum, median and maximum ZnPP/H associated with lower BSID-III scores, but did not reach statistical significance (p > 0.05). The associations between ferritin values and BSID scores were less consistent.
A positive association was seen between ZnPP/H values and BSID-III scores. Trends between ferritin and BSID values were less consistent, potentially because ferritin is more affected by inflammation. Consideration should be given to using ZnPP/H preferentially to adjust iron supplementation in the NICU to improve neurodevelopmental outcomes.
大脑发育关键期的缺铁与神经发育结果不理想有关。确定与神经发育结果相关性最佳的新生儿铁状态标志物对于优化新生儿铁补充剂的管理至关重要。
我们旨在评估两种铁充足的标志物,即铁蛋白和锌原卟啉与血红素比值(ZnPP/H),并将其与神经发育结果进行比较。
这是一项回顾性队列研究。
所有在 2014 年 10 月至 2017 年 4 月期间同时进行铁蛋白和 ZnPP/H 测量,并在 24 个月校正年龄时接受贝利婴幼儿发展量表第三版(BSID-III)评估的婴儿均纳入研究。
评估了 62 名婴儿的 223 项实验室测量值。平均胎龄为 28.1 周(标准差=2.6),平均出生体重为 1.1 千克(标准差=0.4)。最大和中位数 ZnPP/H 与运动评分之间,以及中位数 ZnPP/H 与认知评分之间存在显著相关性。较高的最小、中位数和最大 ZnPP/H 与较低的 BSID-III 评分相关的趋势也存在,但未达到统计学意义(p>0.05)。铁蛋白值与 BSID 评分之间的相关性则不太一致。
ZnPP/H 值与 BSID-III 评分之间存在正相关。铁蛋白与 BSID 值之间的相关性趋势则不太一致,这可能是因为铁蛋白更容易受到炎症的影响。在新生儿重症监护病房(NICU)中,应考虑优先使用 ZnPP/H 来调整铁补充剂,以改善神经发育结果。